Vanguard Group Inc. Has $13.22 Million Position in 908 Devices Inc. (NASDAQ:MASS)

Vanguard Group Inc. grew its position in 908 Devices Inc. (NASDAQ:MASS) by 0.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,751,102 shares of the company’s stock after purchasing an additional 6,772 shares during the period. Vanguard Group Inc. owned about 0.05% of 908 Devices worth $13,221,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. SG Americas Securities LLC bought a new position in 908 Devices during the 4th quarter valued at about $133,000. New York State Common Retirement Fund increased its holdings in shares of 908 Devices by 5.0% during the fourth quarter. New York State Common Retirement Fund now owns 74,033 shares of the company’s stock worth $831,000 after buying an additional 3,508 shares in the last quarter. Iron Triangle Partners LP raised its stake in shares of 908 Devices by 31.1% in the fourth quarter. Iron Triangle Partners LP now owns 1,284,947 shares of the company’s stock valued at $14,417,000 after acquiring an additional 304,484 shares during the last quarter. Granahan Investment Management LLC boosted its holdings in shares of 908 Devices by 10.6% in the 4th quarter. Granahan Investment Management LLC now owns 2,038,658 shares of the company’s stock worth $22,874,000 after acquiring an additional 195,368 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System acquired a new position in shares of 908 Devices in the 1st quarter worth approximately $80,000. Institutional investors own 88.06% of the company’s stock.

Analysts Set New Price Targets

Separately, Stephens reaffirmed an “overweight” rating and set a $14.00 price target on shares of 908 Devices in a report on Monday, May 13th.

908 Devices Price Performance

Shares of NASDAQ MASS opened at $4.25 on Wednesday. 908 Devices Inc. has a 12-month low of $4.24 and a 12-month high of $12.51. The firm’s 50-day simple moving average is $5.30 and its 200 day simple moving average is $6.17. The company has a market cap of $146.56 million, a price-to-earnings ratio of -3.97 and a beta of 1.02.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.